Home » Cornerstone Therapeutics Acquires Cardiokine; NDA Filed Prior to Deal
Cornerstone Therapeutics Acquires Cardiokine; NDA Filed Prior to Deal
Respiratory treatments company Cornerstone Therapeutics is broadening its offerings with the acquisition of cardiovascular drug company Cardiokine Biopharma.
MedcityNews
MedcityNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May